Shanghai Shen Lian Biomedical Corporation (SHA:688098)

China · Delayed Price · Currency is CNY

8.37

+0.05 (0.60%)

Aug 4, 2026, 3:00 PM CST

SHA:688098 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	272.12	288.27	303.41	301.49	328.59	358.43
Revenue Growth	-7.47%	-4.99%	0.64%	-8.25%	-8.32%	6.13%
Gross Profit	157.04	163.8	182.8	213.59	247.21	271.42
Operating Income	-26.45	-29.67	-33.67	27.7	67.56	110.29
Net Income	-19.21	-20.5	-44.74	31.52	61.1	110.2
Earnings Per Share	-0.05	-0.05	-0.11	0.08	0.15	0.27
EPS Growth	-	-	-	-46.67%	-44.44%	-12.90%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	83.29	154.82	190.02	207.35	357.87	468.29
Total Debt	14.09	14.17	15.49	1.25	0.45	0.51
Net Cash (Debt)	69.2	140.65	174.53	206.1	357.42	467.78
Net Cash Growth	-44.70%	-19.41%	-15.32%	-42.34%	-23.59%	-20.32%
Net Cash Per Share	0.17	0.34	0.43	0.52	0.88	1.15

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	21.56	33.08	89.36	3.53	9.09	90.12
Capital Expenditures	-41.96	-45.23	-84.91	-129.63	-93.12	-188.16
Free Cash Flow	-20.4	-12.16	4.45	-126.11	-84.04	-98.04
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	57.71%	56.82%	60.25%	70.85%	75.23%	75.72%
Operating Margin	-9.72%	-10.29%	-11.10%	9.19%	20.56%	30.77%
Pretax Margin	-9.19%	-9.13%	-18.72%	12.03%	22.69%	35.15%
Profit Margin	-7.06%	-7.11%	-14.75%	10.45%	18.59%	30.75%
FCF Margin	-7.50%	-4.22%	1.47%	-41.83%	-25.57%	-27.35%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.035	0.080
Dividend Per Share Growth	-56.25%	-
Dividend Yield	0.47%	1.03%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	97.45	53.36	41.14
Forward PE	-	24.74	24.74	27.70	-	-
P/FCF Ratio	-	-	504.58	-	-	-
PS Ratio	12.53	12.65	7.40	10.19	9.92	12.65